APA (7th ed.) Citation

F, L., M, O., R, C. I., B, G., L, G., C, P., . . . L, M. (2025). Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: A 2-Year Real-Life Multicenter Study. American journal of clinical dermatology, 26(3), 425. https://doi.org/10.1007/s40257-025-00926-y

Chicago Style (17th ed.) Citation

F, Leo, et al. "Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: A 2-Year Real-Life Multicenter Study." American Journal of Clinical Dermatology 26, no. 3 (2025): 425. https://doi.org/10.1007/s40257-025-00926-y.

MLA (9th ed.) Citation

F, Leo, et al. "Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: A 2-Year Real-Life Multicenter Study." American Journal of Clinical Dermatology, vol. 26, no. 3, 2025, p. 425, https://doi.org/10.1007/s40257-025-00926-y.